Clinical Trials
17 trialsNCT04535401 2024-10-10
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
National Cancer Institute (NCI)
Phase 1 Unknown
NCT03835663 2024-03-26
The Bacterial Composition of the Stomach in Reflux Disease
Imperial College London
Unknown
NCT05945082 2023-07-14
Fusobacterium Nucleatum at Colorectal Cancer Sites
Malmö University
Phase NA Unknown
NCT05195502 2023-02-08
COLATA
Bispebjerg Hospital
Unknown
NCT05619016 2022-11-30
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
Karolinska University Hospital
Phase 2 Unknown
NCT03140592 2021-03-19
Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue
Stony Brook University
Unknown
NCT03500068 2021-01-19
OPT-1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Unknown
NCT03544255 2020-01-07
Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Unknown
NCT02809898 2019-10-17
The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer
RenJi Hospital
Unknown
NCT03228095 2018-08-21
Volatolome
University of Latvia
Unknown
NCT03577808 2018-08-20
Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer
Fudan University
Unknown
NCT03140007 2017-05-08
Cholangioscopy
Asian Institute of Gastroenterology, India
Phase NA Unknown
NCT02931981 2016-10-13
Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor
RenJi Hospital
Unknown
NCT00566800 2013-09-17
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01442506 2011-09-28
Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett's Esophagus
Johannes Gutenberg University Mainz
Unknown
NCT00471484 2011-06-22
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00513266 2009-08-07
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown